Guru Ownership Trend
Guru Analysis for Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. (TSHA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.27 M.
Top institutional holders include Louis Moore Bacon and Jefferies Group.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $5.71 M net outflow during the quarter.
Recent activity highlights Louis Moore Bacon who increased their stake by 9.0%. Conversely, Jefferies Group reduced exposure by 31.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Taysha Gene Therapies, Inc. (TSHA)
Major holders include Louis Moore Bacon ($2.44 M), Jefferies Group ($2.24 M), Cliff Asness ($876,883). According to the latest reported data, 3 tracked investment managers collectively hold approximately 815,938 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $5.71 M, with 1 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 3 fully exited TSHA. The total reported sell value was $5.91 M.
Yes, 0 managers opened new positions in TSHA, and 1 increased their existing holdings. The total reported buy value was $201,187.83.